標(biāo)題: Titlebook: Aptamers for Medical Applications; From Diagnosis to Th Yiyang Dong Book 2021 Springer Nature Singapore Pte Ltd. 2021 Aptamer.SELEX.Drug De [打印本頁(yè)] 作者: Remodeling 時(shí)間: 2025-3-21 18:50
書目名稱Aptamers for Medical Applications影響因子(影響力)
書目名稱Aptamers for Medical Applications影響因子(影響力)學(xué)科排名
書目名稱Aptamers for Medical Applications網(wǎng)絡(luò)公開(kāi)度
書目名稱Aptamers for Medical Applications網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Aptamers for Medical Applications被引頻次
書目名稱Aptamers for Medical Applications被引頻次學(xué)科排名
書目名稱Aptamers for Medical Applications年度引用
書目名稱Aptamers for Medical Applications年度引用學(xué)科排名
書目名稱Aptamers for Medical Applications讀者反饋
書目名稱Aptamers for Medical Applications讀者反饋學(xué)科排名
作者: 哎呦 時(shí)間: 2025-3-21 23:50
Karolin Kalmbach,Elke Kleinau,Susanne V?lkerepatitis, AIDS and COVID-19, as well as their application for infectious diseases profiling and cellular monitoring. It can be anticipated that aptamers will play a pivotal role in the future development of advanced diagnostic techniques of intricate infectious diseases.作者: dysphagia 時(shí)間: 2025-3-22 03:24 作者: Glower 時(shí)間: 2025-3-22 05:05
Humanitarian and Political Legaciessuch as metal ions, chemical compounds, proteins, cells, and whole microorganisms. Aptamers are also different from antibodies. They can be easily obtained by chemical methods to extend their life in biological fluids and their bioavailability in animals. Due to their characteristics of binding liga作者: ORBIT 時(shí)間: 2025-3-22 09:32 作者: 有常識(shí) 時(shí)間: 2025-3-22 16:56
Aptamer-Based Drug Delivery Systems,amer-based drug delivery for disease treatment are systematically reviewed. The recent advances in aptamers?as therapeutics, aptamer-drug conjugates (ApDCs) and aptamer-functionalized nanoparticle drug delivery systems are summarized. The present challenges and future perspectives are also discussed作者: cravat 時(shí)間: 2025-3-22 18:59
Aptamers for the Diagnosis of Infectious Diseases,epatitis, AIDS and COVID-19, as well as their application for infectious diseases profiling and cellular monitoring. It can be anticipated that aptamers will play a pivotal role in the future development of advanced diagnostic techniques of intricate infectious diseases.作者: 勉強(qiáng) 時(shí)間: 2025-3-22 21:26 作者: 同謀 時(shí)間: 2025-3-23 03:38
Hormone Aptamers in Endocrine-Related Diseases,such as metal ions, chemical compounds, proteins, cells, and whole microorganisms. Aptamers are also different from antibodies. They can be easily obtained by chemical methods to extend their life in biological fluids and their bioavailability in animals. Due to their characteristics of binding liga作者: 吹牛大王 時(shí)間: 2025-3-23 07:19 作者: 咽下 時(shí)間: 2025-3-23 11:12 作者: glowing 時(shí)間: 2025-3-23 16:16 作者: acclimate 時(shí)間: 2025-3-23 19:57
Aptamer-Based Point of Care Testing Schemes,eing considered for use in point-of-care testing (POCT). Relevant technologies include lateral flow test strips, interferometry, DNA origami nanoboxes, capacitive aptasensors, microfluidics, nanoparticle-based aptasensors, and multiplex technologies suitable for rapid and facile POCT schemes. Advant作者: Perigee 時(shí)間: 2025-3-24 00:46
Aptamer-Based Drug Delivery Systems,he side effects. Aptamers are single-stranded RNA or DNA with high binding affinity and specificity against their corresponding targets, such as metal ions, peptides, proteins, and living cells. Compared with classic antibodies, aptamers have many superiorities, such as small size, little immunogeni作者: 不幸的人 時(shí)間: 2025-3-24 04:47 作者: GIST 時(shí)間: 2025-3-24 09:24
Aptamers for Targeted Therapy,athy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmac作者: URN 時(shí)間: 2025-3-24 10:40
Aptamers for Personalized Therapeutics,e modern diagnosis, bioimaging, drug delivery, and more specifically in personalized therapeutics. Aptamers have the potential of serving as therapeutic molecules alone but they are more effective in combination with drugs and nanomaterials for the sake of targeting or as delivery agents against bro作者: Adenoma 時(shí)間: 2025-3-24 17:16
Aptamers for the Diagnosis of Infectious Diseases,logical information have been successfully applied in infection diagnosis. However, these methods are either relatively complicated or time-consuming. Aptamer, a specific DNA/RNA binder, can serve as field-deployable sensors (termed aptasensors), and is thus highly promising to construct point-of-us作者: 閃光東本 時(shí)間: 2025-3-24 19:20
Aptamers for the Diagnosis of Malign Tumors,to improve the strategy of early diagnosis for malign tumors. Aptamers are single-stranded oligonucleotide ligands with excellent chemical properties such as high affinity, easy synthesis, controllable chemical modifications, low immunogenicity, high stability, and fast tissue penetration. Therefore作者: intolerance 時(shí)間: 2025-3-25 01:52
Aptamers for Thrombotic Diseases, (AMI), acute coronary syndromes (ACS), and thrombotic diseases. Nowadays, thrombotic diseases are the leading causes of morbidity and mortality which incur substantial healthcare expenditures worldwide. There are some shortcomings for current antithrombotics including bleeding potential, unpredicta作者: Madrigal 時(shí)間: 2025-3-25 05:05 作者: Arthritis 時(shí)間: 2025-3-25 07:31 作者: 公社 時(shí)間: 2025-3-25 13:58 作者: 喃喃訴苦 時(shí)間: 2025-3-25 17:52 作者: 虛情假意 時(shí)間: 2025-3-25 21:21 作者: 整理 時(shí)間: 2025-3-26 01:00 作者: 掃興 時(shí)間: 2025-3-26 06:25
Humanitarian and Political Legaciesoblem during the process from bench to bed. Nevertheless, a large number of experimental studies and some successful cases will give us the solid confidence in the clinical application of aptamers in the near future.作者: colloquial 時(shí)間: 2025-3-26 08:40 作者: 細(xì)頸瓶 時(shí)間: 2025-3-26 13:04 作者: 以煙熏消毒 時(shí)間: 2025-3-26 18:22 作者: nonchalance 時(shí)間: 2025-3-26 22:50 作者: larder 時(shí)間: 2025-3-27 01:48
?Race‘ – Class – Gender – Queerication, has evolved into many variations. SELEX and its variants are very useful for the selection of effective aptamers, which provide ideal diagnostic and therapeutic molecules for medical research at the molecular level.作者: 抵消 時(shí)間: 2025-3-27 08:54
Von der , zur Vielfalt der K?mpfedevices related clinical trials, patents, and papers were introduced from two aspects according to their application in “diagnosis” and “therapies,” respectively. Finally, we proposed our perspectives and insights for the development of aptamer-based medical devices.作者: conjunctivitis 時(shí)間: 2025-3-27 11:41
Von der , zur Vielfalt der K?mpfeing several analyses approaches for protein biomarkers, circulating tumor cells, and cancer-related exosomes. The recent imaging techniques for tumor visual measurement are briefly expounded. Furthermore, the challenges and perspectives for the clinical application of aptamer-based methods are discussed.作者: Coterminous 時(shí)間: 2025-3-27 15:16 作者: 半身雕像 時(shí)間: 2025-3-27 21:00 作者: 記憶 時(shí)間: 2025-3-28 01:08 作者: 大漩渦 時(shí)間: 2025-3-28 04:32 作者: synovium 時(shí)間: 2025-3-28 07:41
Book 2021include?aptamer?pharmaceuticals, aptamers for malign tumors, aptamers for personalized therapeutics?and aptamers for point-of-care testing. The book offers an essential guide for medical scientists interested in developing?aptamer-based schemes for better theranostics. It is therefore of interest fo作者: FOIL 時(shí)間: 2025-3-28 12:56
mer-based research and the latest advances.Promotes an in-de.This book?outlines?comprehensively?the main medical uses of aptamers, from diagnosis to therapeutics in fourteen chapters. Pioneering topics covered include?aptamer?pharmaceuticals, aptamers for malign tumors, aptamers for personalized the作者: 搖擺 時(shí)間: 2025-3-28 18:34
Karolin Kalmbach,Elke Kleinau,Susanne V?lker, capacitive aptasensors, microfluidics, nanoparticle-based aptasensors, and multiplex technologies suitable for rapid and facile POCT schemes. Advantages of using aptamers over antibodies in such POCT platforms are elucidated in each case.作者: Headstrong 時(shí)間: 2025-3-28 19:33
Karolin Kalmbach,Elke Kleinau,Susanne V?lkerrs. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.作者: 培養(yǎng) 時(shí)間: 2025-3-29 02:22 作者: Generator 時(shí)間: 2025-3-29 04:32 作者: Mri485 時(shí)間: 2025-3-29 07:31
Book 2021ffers an essential guide for medical scientists interested in developing?aptamer-based schemes for better theranostics. It is therefore of interest for?not only?academic researchers, but also practitioners and medical researchers in various fields of medical science, medical research?and bio-analytical chemistry.??.作者: Pituitary-Gland 時(shí)間: 2025-3-29 14:32 作者: 鋼筆記下懲罰 時(shí)間: 2025-3-29 15:51 作者: DAFT 時(shí)間: 2025-3-29 20:45
Karolin Kalmbach,Elke Kleinau,Susanne V?lkernt stages of diseases. The key to molecular imaging techniques is molecular probes and contrast agents. Aptamers, often called “chemical antibodies”, are short oligonucleotides with high affinity and specificity to the target binding domain. They are highly reproducible, nontoxic/immunogenic, and co作者: 戰(zhàn)役 時(shí)間: 2025-3-30 00:54 作者: 繼承人 時(shí)間: 2025-3-30 06:46 作者: 碎石 時(shí)間: 2025-3-30 08:59
Von der , zur Vielfalt der K?mpfeucleotides that can specifically bind to their targets. They are promising alternatives of antibodies in the field of medical devices owing to the property of specific binding to their targets, as well as the advantages such as easy synthesis and modification, chemical stability, low immunogenicity,作者: rheumatology 時(shí)間: 2025-3-30 12:32
Karolin Kalmbach,Elke Kleinau,Susanne V?lkerathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmac作者: optional 時(shí)間: 2025-3-30 16:54 作者: 無(wú)法取消 時(shí)間: 2025-3-30 21:20
Karolin Kalmbach,Elke Kleinau,Susanne V?lkerlogical information have been successfully applied in infection diagnosis. However, these methods are either relatively complicated or time-consuming. Aptamer, a specific DNA/RNA binder, can serve as field-deployable sensors (termed aptasensors), and is thus highly promising to construct point-of-us作者: 技術(shù) 時(shí)間: 2025-3-31 03:20 作者: DALLY 時(shí)間: 2025-3-31 08:22
Von der , zur Vielfalt der K?mpfe (AMI), acute coronary syndromes (ACS), and thrombotic diseases. Nowadays, thrombotic diseases are the leading causes of morbidity and mortality which incur substantial healthcare expenditures worldwide. There are some shortcomings for current antithrombotics including bleeding potential, unpredicta
